Cotransplantation of haploidentical hematopoietic stem cells and allogeneic bone marrow-derived mesenchymal stromal cells as a first-line treatment in very severe aplastic anemia patients with refractory infections.
Chunyan YueYingying DingYang GaoLi LiYan PangZenghui LiuHang ZhangYang XiaoZujun JiangHaowen XiaoPublished in: European journal of haematology (2018)
Upfront HRD-HSCT may be a safe and promising choice for patients with VSAA in critical situations without suitably matched donors.
Keyphrases
- bone marrow
- stem cells
- mesenchymal stem cells
- stem cell transplantation
- hematopoietic stem cell
- chronic kidney disease
- allogeneic hematopoietic stem cell transplantation
- iron deficiency
- early onset
- cell therapy
- kidney transplantation
- acute myeloid leukemia
- decision making
- drug induced
- acute lymphoblastic leukemia
- low dose
- peripheral blood